Severe combined immunodeficiency: New advances in diagnosis and treatment

Immunologic Research

Volumn 38, Issue 1-3, 2007, Pages 64-67

  Puck, Jennifer M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone marrow transplantation; Common gamma chain; Gene therapy; IL2RG; Leukemia; Newborn screening; Retrovirus; Severe combined immunodeficiency (SCID); T cell receptor excision circle (TREC); X linked inheritance

Indexed keywords

BLOOD DONOR; BONE MARROW TRANSPLANTATION; CELLULAR IMMUNITY; COMBINED IMMUNODEFICIENCY; CONFERENCE PAPER; GENE THERAPY; HEMATOPOIETIC STEM CELL; HUMAN; HUMORAL IMMUNITY; MUTAGENESIS; NEWBORN SCREENING; PRIORITY JOURNAL;

EARLY DIAGNOSIS; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 35348879697     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-007-0029-8     Document Type: Conference Paper

References (14)

1. Puck JM. X-linked severe combined immunodeficiency. In: Ochs H, Smith CIE, Puck JM, editors. Primary immunodeficiency diseases, a molecular and genetic approach. 2nd ed. New York, NY: Oxford University Press; 2007 (Chapter 9)
2. Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968;7583:946-7
3. Haddad E, Landais P, Friedrich W, et al. Long term immune reconstitution and outcome after HLA-nonidentical T-cell depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood 1998;91:3646-53
4. Buckley RH, Schiff SE, Schiff RI, et al. Hematopoietic stem cell transplantation for the treatment of severe combined immunodeficiency. New Engl J Med 1999;340:508-16
5. Antoine C, Muller S, Cant A, et al. Long-term survival and transplantation of hematopoietic stem cells for immunodeficiencies: report of the European experience 1968-1999. Lancet 2003;361:553-6
6. Buckley RH, Fischer A. Bone marrow transplantation for primary immunodeficiency diseases. In: Ochs H, Smith CIE, Puck JM, editors. Primary immunodeficiency diseases, a molecular, genetic approach. 2nd ed. New York NY: Oxford University Press; 2007 (Chapter 47)
7. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000;288:669-72
8. Aiuti A, Slavin S, Aker M, et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 2002;296:2410-3
9. Gaspar HB, Parsley KL, Howe S, et al. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 2004;364:2181-7
10. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003;302:415-9
11. Chinen J, Davis J, De Ravin SS, et al. Gene therapy improves immune function in pre-adolescents with X-linked severe combined immunodeficiency. Blood 2007 (in press)
12. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998;396:690-5
13. Myers LA, Patel DD, Puck JM, Buckley RH. Hematopoietic stem cell transplantation for SCID in the neonatal period leads to superior thymic output and improved survival. Blood 2002;99:872-8
14. Chan K, Puck JM. Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol 2005;115:391-8